Below are the June Medical Staff Updates. As a reminder, all providers must complete the attestation at the bottom of this page by June 30.
This has been a year focused on the move to the new Oishei Children’s Hospital, continued quality improvement, and expansion across the region. It is also time to prepare for our pending DNV GL accreditation, including our certification to the ISO 9001:2015 standards, which will likely occur in September/October. Considerable resources have been dedicated to maintain a continuous state of readiness with daily rounding. Your partnership is greatly appreciated as we prepare for the upcoming survey. It is important that you are aware of the prior NCs (nonconformities) as it is critical that we do not have another citation in any of these areas. Below are the areas previously cited:
• Staffing Management/Anesthesia Services:
Per documentation, appears that nursing is administering deep sedation (out of their professional scope)
• Patient Rights – Restraints:
Per Restraints Safety Stand-down, all renewal orders must be renewed by 0930. Co-signature for orders written by residents and advance practice providers
• Patient Rights:
Ensure there is documentation of language interpretive services in the EMR
• Medication Management:
All medications and sharps must be kept secure at all times
• Infection Control & Prevention:
Do NOT pre-open supplies (especially intubation blades prior to using). For anyone passing the threshold of the patient’s door, if on precautions, all staff and providers must don PPE, even if not touching patient or surfaces. Same rule applies for practicing hand hygiene
• H&Ps and Operative Notes:
H&Ps must be available in the chart or done electronically within 30 days of procedure. Consents must be complete (including date/time) and provider performing procedure must sign, date and time provider attestation. Operative notes – all required elements must be present and done prior to patient moving to the next level of care
The move to Oishei Children’s Hospital is on schedule. The team has been preparing all aspects of the move including traffic control, vehicles, volunteers and medical leadership to ensure our patients and staff are transitioned safely to their new home. Patient experience remains the one area that, despite considerable efforts, does not reflect the level of care we deliver. Many initiatives will be highly visible over the next several months, and we ask for your help and partnership in championing these efforts.
David Hughes, MD, MPH
Chief Medical Officer
Kenneth Snyder, MD, PhD
Vice President, Physician Quality
Colin McMahon, MD
Chief Medical Officer
Buffalo General Medical Center/Gates Vascular Institute
David Pierce, MD, FACEP
Chief Medical Officer
Millard Fillmore Suburban Hospital and DeGraff Memorial Hospital
Stephen Turkovich, MD
Chief Medical Officer
Women & Children’s Hospital of Buffalo
One of the most important tasks of the Medical Executive Committee (MEC) is to support the quality of care delivered by Medical/Dental Staff members. The Peer Review Committee is charged with providing this key MEC function. Over the past several years, the Peer Review Committee has been evolving its approach to quality in partnership with Maralyn Militello and her quality team. The committee has reviewed its approach to medical record reviews, case identification and provider feedback. Michael Pizzuto, MD, has provided exceptional leadership as chair of the Peer Review Committee during this process over the past few years. He is now stepping down at the end of his term. We are fortunate that he will remain in a physician leadership role as chief of service for ENT. Mike, on behalf of the MEC, and personally, you have my deepest thanks and appreciation for all of your work with Peer Review.
I am very pleased that Jo Anne Arnold, MD, has agreed to fill the chair position for the Peer Review Committee. I have the utmost confidence that Jo Anne will continue the evolution of the committee and bring it to the next level. I also want to thank Vincent Callanan, MD, for agreeing to serve in the position of physician champion of the newly-created Medical Records Committee.
The MEC can only do its work because of physician leaders like Mike, JoAnne and Vincent. If you see them, or any of the members of the MEC, please be sure to show your appreciation for their dedication and hard work.
Peter Winkelstein, MD, MS, MBA, FAAP
Medical/Dental Staff President
On April 27, 2017, Kaleida Health hosted its first ever joint Medical/Dental Staff Semiannual Meeting with ECMC. David Rich, executive vice president, government affairs, communications, and public policy, Greater New York Hospital Association, was the guest speaker. In addition, leaders from Kaleida Health and ECMC gave brief updates at the meeting.
Click HERE to watch the presentations from the meeting.
As Kaleida Health continues on its Leading with CARE journey, the organization is seeing a positive impact on the quality of care patients receive.
Last year, Leading with CARE focused on creating a culture of safety using the concept “See, Say, Do.”
Through everyone’s hard work and commitment over the past year, Kaleida Health has made tremendous progress in ensuring a safe environment by engaging employees and physicians to do the right thing, improving quality and processes, and leading at the bedside.
This year, the organization is taking Leading with CARE back to the very roots and basis of health care: empathy and compassion. The “home grown” course is based upon real experiences from Kaleida Health employees who have been patients or have had loved ones as patients in one of our facilities.
Providers are strongly encouraged to participate in a Leading with CARE class focused on how to be empathetic and compassionate toward patients, families, visitors and co-workers every day.
This year’s class will be a 30-minute, web-based course completed through Talent Management. The online classes will only be available on Talent Management until Tuesday, August 1, 2017.
As Kaleida Health continues to improve the patient experience, we must maintain the positive momentum of Leading with CARE. With each member of the ever-growing Kaleida Health family focused on caring with empathy and compassion, we should have full confidence that we can continue to make a difference for our patients, visitors, colleagues and the entire community.
Congratulations to Gerald Sufrin, MD, chief of service for urology, who received the Lifetime Achievement Award from the American Urological Association (AUA).
Dr. Sufrin received the award for his outstanding dedication to urologic education, research and advocacy at the National Institutes of Health (NIH). He also served as treasurer of the AUA during construction of the new AUA Headquarters building.
Mark your calendar for the fourth annual Gates Vascular Institute Symposium: Updates in Cardiac, Vascular & Neuroendovascular Medicine.
This year's event will take place on Friday, October 13, 2017 and Saturday, October 14, 2017. Please note the new location:
The Grapevine Banquets
333 Dick Road
Depew, NY 14043
Visit the Gates Vascular Institute Symposium website for additional details.
The FibroScan® medical device was FDA approved late in 2013 and was purchased for clinical research purposes with patients with various liver diseases. The device can quantify measurements of both the steatosis and fibrosis of a patient’s liver in real time in about 5-10 minutes.
The device is a non-invasive tool which uses a 50Hz shear-wave (mechanical sound wave) and 3.5MHz ultrasound coefficient of attenuation (CAP) to obtain multiple measurements of the liver externally using a probe. The probe is placed on the skin located optimally between ribs of a patient’s right side. Multiple measurements (a minimum of 10) are taken, which are painless and are obtained on a patient who have fasted a minimum of three hours. The system reports on two parameters: steatosis (amount of fat in the liver) and liver stiffness (amount of fibrosis or scarring of the liver). The report is then reviewed by the liver specialist. The known liver disease etiology is correlated with other tests and blood results to help stage or grade any abnormal values found.
The FibroScan® is currently being used in research; however, direct clinical applications for use are being targeted. The quantified measurements can aid the hepatologist with determining if changes in the liver health are occurring and help to stratify the clinical management of these patients. For more information on FibroScan® or for the currently active clinical liver disease research studies at University at Buffalo, please contact Rick Rejman at 878-3320.
Please welcome the following new appointments to Kaleida Health:
Below are the new and revised policies that affect providers at Kaleida Health. Please take a moment to review this month's updates. The policy links below are accessible from a Kaleida Health computer only. For additional assistance, please contact Amy Palombo at email@example.com or 716-859-8447.
MED.44 – Shadowing/Observing Medical/Dental Staff Member
ED.1120 – Rapid Sequence Intubation in a Critical Care Setting
LE.15 – Minor Patient Leaving Against Medical Advice (AMA) or Absconding (Elopement) from Emergency Department and All Acute In-Patient Departments
By submitting this attestation, I confirm that as a member of the medical staff I have read and understand the information included in this email from Kaleida Health in accordance with Kaleida Health policy MED.41 as approved by the Medical Executive Committee.
|Fields marked with an asterisk (*) are required.